FAM225A and nasopharyngeal carcinoma: FAM225A blocks the activity of miR-590-3p and miR-1275, leading to increased levels of integrin β3 (ITGB3) and, consequently, activation of the FAK/PI3K/Akt signalling pathway to promote NPC cell proliferation and invasion [169].